Targeted therapy or checkpoint inhibitors in melanoma: which is better?
Dirk Schadendorf • 2 Jun 2017
Development of novel treatments in melanoma patients with BRAF mutations
Dirk Schadendorf • 27 Jan 2017
Adipocytes in the tumor microenvironment: an emerging target for melanoma treatment